Come up with a name for your new list and we'll add to it:
Transkaryotic Therapies raised a round of funding on , . Investors include
Thomas McNerney & Partners.
Transkaryotic Therapies (NASDAQ: TKTX) develops technologies for the production of human proteins and for gene therapy systems. Products developed with these technologies include ReplagalT, a drug app…